What is DiaMedica Therapeutics Inc (DMAC) stock price today?

DiaMedica Therapeutics Inc (DMAC) currently trades at $6.05 per share. The stock has a market capitalization of $341.08M and a P/E ratio of —x.

Is DMAC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, DiaMedica Therapeutics Inc has a Smart Value Score of 20/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

DMAC

DiaMedica Therapeutics Inc

NASDAQ: DMAC · HEALTHCARE · BIOTECHNOLOGY

$6.05

+1.51% today

Updated 2026-04-30

Market cap

$341.08M

P/E ratio

—

P/S ratio

66.68x

EPS (TTM)

$-0.70

Dividend yield

—

52W range

$3 – $10

Volume

0.2M

Market cap

$341.08M

P/E ratio

—

P/S ratio

66.68x

EPS (TTM)

$-0.70

Dividend yield

—

52W range

$3 – $10

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$15.50

+156.20%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-7.77M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$-27999.00
Net income	$-13.68M	$-19.38M	$-24.44M	$-32.77M	$-8.74M
EPS	—	—	—	—	$-0.70
Free cash flow	$-11.59M	$-18.75M	$-22.10M	$-29.10M	$-7.77M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-01-02	SEMBA, CHARLES PAULING	Buy	3,355	$8.42
2026-01-02	PARSONS, JAMES T.	Buy	10,095	$8.42
2026-01-02	GIUFFRE, RANDALL MICHAEL	Buy	6,175	$8.42

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DMAC	$341.08M	20	4.3	3.0	5.0	5.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

DiaMedica Therapeutics Inc trades at $6.05. Our Smart Value Score of 20/100 indicates the stock is weak.

Frequently asked questions

What is DiaMedica Therapeutics Inc's stock price?

DiaMedica Therapeutics Inc (DMAC) trades at $6.05.

Is DiaMedica Therapeutics Inc overvalued?

Smart Value Score 20/100 (Grade F, Strong Sell).

What is the price target of DiaMedica Therapeutics Inc (DMAC)?

The analyst target price is $15.50, representing +156.2% upside from the current price of $6.05.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio66.68x

ROE-67.70%

Beta1.15

50D MA$7.24

200D MA$6.98

Shares out0.05B

Float0.03B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

DMAC vs LLY →DMAC vs JNJ →DMAC vs ABBV →Stock screener →